---
title: "OBIO.US (OBIO.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/OBIO.US/news.md"
symbol: "OBIO.US"
name: "OBIO.US"
parent: "https://longbridge.com/zh-CN/quote/OBIO.US.md"
datetime: "2026-03-15T14:29:07.290Z"
locales:
  - [en](https://longbridge.com/en/quote/OBIO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OBIO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OBIO.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/OBIO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/OBIO.US/news.md)


# OBIO.US (OBIO.US) — 相关新闻

### [Orchestra BioMed Holdings 10-K Summary — Revenue: $— | EPS: $—](https://longbridge.com/zh-CN/news/278882251.md)
*2026-03-12T12:15:00.000Z*
> Orchestra BioMed Holdings filed its Form 10-K, disclosing no revenue or earnings per share figures. The report discusses

### [Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update | OBIO Stock News](https://longbridge.com/zh-CN/news/278882558.md)
*2026-03-12T04:20:46.000Z*
> Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update | OBIO Stock News

### [Orchestra Biomed Announces Presentations Highlighting Avim Therapy Potential Impact On Hypertensive Heart Disease And Heart Failure At Tht And Crt](https://longbridge.com/zh-CN/news/277627256.md)
*2026-03-03T13:10:18.000Z*
### [Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of "Moderate Buy" by Brokerages](https://longbridge.com/zh-CN/news/276528649.md)
*2026-02-22T06:46:07.000Z*
> Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has received a consensus rating of "Moderate Buy" from seven research firm

### [Orchestra BioMed (NASDAQ:OBIO) Trading 4.2% Higher   - Here's What Happened](https://longbridge.com/zh-CN/news/276316062.md)
*2026-02-19T08:56:44.000Z*
> Orchestra BioMed (NASDAQ:OBIO) shares rose 4.2% to $4.00 during mid-day trading, with a trading volume of 109,089 shares

### [Orchestra Biomed Unveils Vision for Growth With Updates on Pivotal Cardiovascular Trials and Strategic Partnerships](https://longbridge.com/zh-CN/news/275020077.md)
*2026-02-05T19:06:52.000Z*
### [Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/zh-CN/news/273968184.md)
*2026-01-28T09:39:34.000Z*
> Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has received a consensus recommendation of "Moderate Buy" from seven broke

### [Orchestra BioMed to Receive Up to $21 Million from Vivasure Sale to Haemonetics](https://longbridge.com/zh-CN/news/272281629.md)
*2026-01-12T14:00:24.000Z*